Show simple item record

Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis

dc.contributor.authorDeyab, Gia
dc.contributor.authorReine, Trine M.
dc.contributor.authorVuong, Tram Thu
dc.contributor.authorJenssen, Trond Geir
dc.contributor.authorHjeltnes, Gunnbjørg
dc.contributor.authorAgewall, Stefan
dc.contributor.authorMikkelsen, Knut
dc.contributor.authorFørre, Øystein
dc.contributor.authorFagerland, Morten
dc.contributor.authorKolset, Svein Olav
dc.contributor.authorHollan, Ivana
dc.date.accessioned2022-03-01T12:47:30Z
dc.date.available2022-03-01T12:47:30Z
dc.date.created2022-01-10T15:10:55Z
dc.date.issued2021
dc.identifier.citationPLOS ONE. 2021, 16 (7), e0253247-?.en_US
dc.identifier.issn1932-6203
dc.identifier.urihttps://hdl.handle.net/11250/2982104
dc.language.isoengen_US
dc.publisherPLoSen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleAntirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritisen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumbere0253247-?en_US
dc.source.volume16en_US
dc.source.journalPLOS ONEen_US
dc.source.issue7en_US
dc.identifier.doi10.1371/journal.pone.0253247
dc.identifier.cristin1977717
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail
Name:
journal.pone.0253247.pdf
Size:
672.0Kb
Format:
PDF
Description:
Deyab
View/Open

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal